Heidi L Wagner sold $189k of WVE
director at Wave Life Sciences Ltd.. 14,000 shares at an average of $13.50, traded Dec 8, 2025, filed Dec 10, 2025.
Score components
- +15RoleDirector
- +12Trade size$189k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-314741, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +7,000 | $5.97 | $42k | 51,930 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -7,000 | $13.00 | $91k | 44,930 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +7,000 | $5.97 | $42k | 51,930 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -7,000 | $14.00 | $98k | 44,930 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -14,000 | $0.00 | $0 | 7,000 | Dec 10, 2025 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | WVEbuy Wave Life Sciences Ltd. | Ra Capital Management, L.p. director, owner | $55M 8,772,496 shares | +48% | |
| 8Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $500k 33,194 shares | -42% | |
| 44Moderate | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $141k 10,480 shares | -4% | |
| 28Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $25k 1,883 shares | -3% | |
| 1Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $150k 9,375 shares | -27% | |
| 39Weak | WVEbuy Wave Life Sciences Ltd. | GSK plc owner | $28M 1,470,000 shares | +9% | |
| 32Weak | Wave Life Sciences Ltd. | Mark Corrigan director | $217k 16,115 shares | -36% | |
| 40Moderate | Wave Life Sciences Ltd. | Chris Francis See Remarks | $6.4M 441,031 shares | -830% | |
| 40Moderate | Wave Life Sciences Ltd. | Christian O Henry director | $1.4M 93,445 shares | -488% | |
| 47Moderate | Wave Life Sciences Ltd. | Kyle Moran Chief Financial Officer | $4.1M 260,036 shares | -174% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.